| STARTSEITE |
 |
|
| Impressum |
| Datenschutz |
 |
 |
| SPOT ON | |
Rebates according to the Pharmaceutical Market Restructuring Act in Germany (AMNOG): how much money save the health insurance funds? | |
| THERAPY FROM A CRITICAL VIEWPOINT | |
Breast cancer: duration of adjuvant treatment with tamoxifen (NOLVADEX, generics) | |
| NEW ON THE MARKET | |
Aflibercept (EYLEA) for exudative macular degeneration | |
| a-t READER'S QUESTIONS AND COMMENTS | |
Emergency contraception - is prescription of levonorgestrel (PIDANA) instead of ulipristal acetate unethical? | |
| IN BRIEF |
Quality control of spironolactone tablets (ALDACTONE, generics) |
| CURRENT ADR NETWORK REPORT | |
 |
Injection site abscess due to paliperidone depot (XEPLION) |
| SIDE EFFECTS | |
Ethinyl estradiol plus cyproterone acetate (in DIANE, generics) in France off market | |
| e a-t IN INTERNET | |
CAVE: tianeptine (TIANEURAX) against depression | |
|
© arznei-telegramm 2/2013 | ||
 |  | |